Cargando…
Angiotensin I–Converting Enzyme Type 2 (ACE2) Gene Therapy Improves Glycemic Control in Diabetic Mice
OBJECTIVE: Several clinical studies have shown the benefits of renin-angiotensin system (RAS) blockade in the development of diabetes, and a local RAS has been identified in pancreatic islets. Angiotensin I–converting enzyme (ACE)2, a new component of the RAS, has been identified in the pancreas, bu...
Autores principales: | Bindom, Sharell M., Hans, Chetan P., Xia, Huijing, Boulares, A. Hamid, Lazartigues, Eric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3279528/ https://www.ncbi.nlm.nih.gov/pubmed/20660625 http://dx.doi.org/10.2337/db09-0782 |
Ejemplares similares
-
The sweeter side of ACE2: Physiological evidence for a role in diabetes
por: Bindom, Sharell M., et al.
Publicado: (2009) -
Angiotensin‐converting enzyme 2 in the brain: properties and future directions
por: Xia, Huijing, et al.
Publicado: (2008) -
Angiotensin-Converting Enzyme 2: Central Regulator for Cardiovascular Function
por: Xia, Huijing, et al.
Publicado: (2010) -
ACE2-Mediated Reduction of Oxidative Stress in the Central Nervous System Is Associated with Improvement of Autonomic Function
por: Xia, Huijing, et al.
Publicado: (2011) -
Neprilysin Is Required for Angiotensin-(1–7)’s Ability to Enhance Insulin Secretion via Its Proteolytic Activity to Generate Angiotensin-(1–2)
por: Brar, Gurkirat S., et al.
Publicado: (2017)